Suchergebnisse - "Freeman, Tom P"

PubPharm (223)

81

Clinical withdrawal symptom profile of synthetic cannabinoid receptor agonists and comparison of effects with high potency cannabis

enthalten in: Psychopharmacology | 2021

von Craft, S. | Ferris, J. | Barratt, M. | +4

82

The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis : findings from the EU-GEI study

enthalten in: Translational psychiatry | 2021

von Quattrone, D. | Reininghaus, U. | Richards, A. | +92

83

Does variation in trait schizotypy and frequency of cannabis use influence the acute subjective, cognitive and psychotomimetic effects of delta-9-tetrahydrocannabinol? A mega-analysis

enthalten in: Journal of psychopharmacology (Oxford, England) | 2021

von Freeman, A. | Mokrysz, C. | Hindocha, C. | +5

84

Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients : the EU-GEI case-control study

enthalten in: Psychological medicine | 2021

von Quattrone, D. | Ferraro, L. | Tripoli, G. | +39

85

The Effects of Acute Δ9-Tetrahydrocannabinol on Striatal Glutamatergic Function : A Proton Magnetic Resonance Spectroscopy Study

enthalten in: Biological psychiatry. Cognitive neuroscience and neuroimaging | 2021

von Bloomfield, M. | Petrilli, K. | Lees, R. | +10

86

A latent class analysis of cannabis use products in a general population sample of adolescents and their association with paranoia, hallucinations, cognitive disorganisation and grandiosity

enthalten in: Addictive behaviors | 2021

von Mackie, C. | Wilson, J. | Freeman, T. | +3

87

Stimulating meditation : a pre-registered randomised controlled experiment combining a single dose of the cognitive enhancer, modafinil, with brief mindfulness training

enthalten in: Journal of psychopharmacology (Oxford, England) | 2021

von Thomas, E. | Freeman, T. | Poplutz, P. | +4

88

Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time : systematic review and meta-analysis

enthalten in: Addiction (Abingdon, England) | 2021

von Freeman, T. | Craft, S. | Wilson, J. | +4

89

Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities : a narrative review

enthalten in: Psychological medicine | 2021

von Lees, R. | Hines, L. | D'Souza, D. | +4

90

Minimum THC unit pricing : an opportunity for harm reduction

enthalten in: Addiction (Abingdon, England) | 2021

von Freeman, T. | Lynskey, M.

CommentOn: Addiction. 2021 Feb;116(2):222-230. - PMID 32621400